599183-43-4

Basic information

• Product Name: Benzamide, N-(5-nitro-1H-indazol-3-yl)-
• CAS NO: 599183-43-4
• Molecular Formula: C14H10N4O3
• Molecular Weight: 282.258
• Mol File: 599183-43-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzamide, N-(5-nitro-1H-indazol-3-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, N-(5-nitro-1H-indazol-3-yl)-(599183-43-4)
• EPA Substance Registry System: Benzamide, N-(5-nitro-1H-indazol-3-yl)-(599183-43-4)

Safety Data

• Hazardous Substances Data: 599183-43-4(Hazardous Substances Data)

Upstream product

• 17417-09-3 2-fluoro-5-nitrobenzonitrile 
• 17420-30-3 5-nitroanthranilonitrile 
• 93-89-0 benzoic acid ethyl ester 
• 60024-27-3 2-amino-5-nitrobenzamidoxime 
• 41339-17-7 5-nitro-1H-indazol-3-amine 
• 98-88-4 benzoyl chloride 

Downstream Products

• 599183-42-3 N-(5-amino-1H-indazol-3-yl)benzamide 

Relevant articles and documents

INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS

The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.

In Silico HTS and Structure Based Optimization of Indazole-Derived ULK1 Inhibitors

We present the outcome of an in silico high throughput screen (HTS) and optimization of a small molecule Unc-51-Like Kinase 1 (ULK1) inhibitor hit, SR-17398, with an indazole core. Docking studies guided design efforts that led to inhibitors with increase

Substituted indazoles, compositions containing them, method of production and use

Substituted indazoles, compositions containing them, method of production and use. The present invention relates in particular to novel specific substituted indazoles exhibiting kinase-inhibiting activity, having therapeutic activity, in particlar in onco